Mustang Bio
MBIO
25 hedge funds and large institutions have $1.4M invested in Mustang Bio in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
14% more capital invested
Capital invested by funds: $1.22M → $1.4M (+$173K)
0.06% more ownership
Funds ownership: 0.16% → 0.22% (+0.06%)
4% less funds holding
Funds holding: 26 → 25 (-1)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$692K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$27.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.65K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$36K |
| 2 |
Barclays
London,
United Kingdom
|
-$8.56K |
| 3 |
Renaissance Technologies
New York
|
-$7.14K |
| 4 |
KOC
Koss-Olinger Consulting
Gainesville,
Florida
|
-$5.79K |
| 5 |
Morgan Stanley
New York
|
-$317 |
MBIO Hedge Fund Activity: Q4 2023 in Review
25 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2023, worth a combined $1.4M — up 14% from $1.22M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MBIO and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $692K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $36K sold.
- 25 institutional investors held Mustang Bio (MBIO) as of Q4 2023, down from 26 in Q3 2023.
- Funds reported $1.4M of Mustang Bio stock for Q4 2023, up 14% quarter-over-quarter.
- 2 funds opened new Mustang Bio positions in Q4 2023 and 3 closed out, a net change of -1 holder.
- The largest Mustang Bio buyer in Q4 2023 was Armistice Capital, an estimated $692K added.
- The largest Mustang Bio seller in Q4 2023 was Dimensional Fund Advisors, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2023.